Understanding how Alzheimer’s and related dementias affect nursing home care for people with serious mental illness
Official title: The Impact of Alzheimer’s Disease and Related Dementias on Nursing Home Care and Quality for Persons with Serious Mental Illness
Funded at University of Michigan at Ann Arbor · NIH-10803736 · Data updated 2026-11-12
This study is looking at how Alzheimer’s disease and serious mental illnesses like bipolar disorder and schizophrenia affect the care of nursing home residents, and it aims to find ways to make that care better for everyone involved.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 30, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $2,109,150 |
| NIH project number | 1RF1AG082011-01A1 |
| Project ID | NIH-10803736 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults residing in nursing homes who have been diagnosed with serious mental illnesses and may also be experiencing Alzheimer’s disease or related dementias.
✕Less likely to help
Patients who do not reside in nursing homes or do not have a diagnosis of serious mental illness or dementia may not benefit from this research.
What this research studies
This research investigates the intersection of Alzheimer’s disease, related dementias, and serious mental illness in nursing home settings. It aims to understand how these conditions impact the quality of care received by residents with serious mental illnesses such as bipolar disorder and schizophrenia. By analyzing data on nursing home residents, the study seeks to identify the unique challenges faced by this population and develop strategies to improve their care. The research will involve collaboration with nursing homes and may include interviews and assessments of care practices.
Why it matters
Potential benefit: If successful, this research could lead to improved care strategies for nursing home residents with serious mental illness and dementia, enhancing their quality of life.
How similar studies have gone: Previous research has highlighted the challenges faced by nursing home residents with serious mental illness, suggesting that this area of study is both relevant and necessary for improving care.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Maust, Donovan T — University of Michigan at Ann Arbor
- Study coordinator: Maust, Donovan T
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.